Zydus may seek jab nod this month1 min read . Updated: 05 May 2021, 12:49 AM IST
- The Ahmedabad-based drugmaker had started the 28,000-participant phase 3 trial of its DNA plasmid vaccine in February
Drugmaker Zydus Cadila is expecting the first set of its interim efficacy data for its covid-19 vaccine this month, following which the company will immediately apply for an emergency use authorization with the Indian regulator, managing director Sharvil Patel said.
Select your Category